BG106814A - Четвъртични соли на n-заместени циклични или ациклични амини като лекарствени средства - Google Patents

Четвъртични соли на n-заместени циклични или ациклични амини като лекарствени средства

Info

Publication number
BG106814A
BG106814A BG106814A BG10681402A BG106814A BG 106814 A BG106814 A BG 106814A BG 106814 A BG106814 A BG 106814A BG 10681402 A BG10681402 A BG 10681402A BG 106814 A BG106814 A BG 106814A
Authority
BG
Bulgaria
Prior art keywords
pharmaceuticals
substituted cyclic
quaternary salts
acyclic amines
acyclic
Prior art date
Application number
BG106814A
Other languages
English (en)
Inventor
Lewis CHOI
Gregory BEATCH
Clive PAGE
Original Assignee
Ucb Farchim S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.
Publication of BG106814A publication Critical patent/BG106814A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретението се отнася до приложението на определени четвъртични амониеви съединения като активна съставка при производството на медикамент за лечение и/или превенция на кашлица при бозайници, включително при хора. Съединенията имат формула Y - J -E An-, в която J е избран независимо от група, представена с една от формулите.
BG106814A 1999-12-15 2002-06-12 Четвъртични соли на n-заместени циклични или ациклични амини като лекарствени средства BG106814A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292350 1999-12-15
PCT/CA2000/001507 WO2001044218A1 (en) 1999-12-15 2000-12-15 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals

Publications (1)

Publication Number Publication Date
BG106814A true BG106814A (bg) 2003-04-30

Family

ID=4164886

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106814A BG106814A (bg) 1999-12-15 2002-06-12 Четвъртични соли на n-заместени циклични или ациклични амини като лекарствени средства

Country Status (21)

Country Link
US (1) US20040214867A1 (bg)
EP (1) EP1278736A1 (bg)
JP (1) JP2003516982A (bg)
KR (1) KR20020075871A (bg)
CN (1) CN1423641A (bg)
AU (1) AU2334601A (bg)
BG (1) BG106814A (bg)
BR (1) BR0016430A (bg)
CZ (1) CZ20022096A3 (bg)
EE (1) EE200200316A (bg)
HU (1) HUP0204014A3 (bg)
IL (1) IL150180A0 (bg)
IS (1) IS6415A (bg)
MX (1) MXPA02006050A (bg)
NO (1) NO20022869L (bg)
NZ (1) NZ519746A (bg)
PL (1) PL355904A1 (bg)
RU (1) RU2002116211A (bg)
WO (1) WO2001044218A1 (bg)
YU (1) YU44202A (bg)
ZA (1) ZA200205568B (bg)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148057B2 (en) * 2005-06-21 2012-04-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Methods, immunoassays and devices for detection of anti-lipoidal antibodies
BRPI0611866B8 (pt) * 2005-06-21 2021-07-27 The Government Of The Us Secretary Of The Department Of Health And Human Services Centers For Diseas dispositivo de fluxo lateral de imunoensaio, dispositivo de fluxo direto de imunoensaio, método para detectar anticorpos antilipoidais em um sujeito, método para para diagnosticar sífilis em um sujeito e métodos para imobilizar cardiolipina imunorreativa sobre um substrato microporoso
KR20090082507A (ko) 2006-11-20 2009-07-30 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
CA3027255C (en) 2009-07-10 2022-06-21 The General Hospital Corporation Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
HUE032240T2 (en) 2011-10-24 2017-09-28 Asana Biosciences Llc cyclohexylamines
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MA55320A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques substitués par un ester et méthodes d'utilisation
EP3937945A4 (en) 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
AU2021236130A1 (en) 2020-03-11 2022-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060637A (en) * 1971-06-21 1977-11-29 Pierre Fabre Sa Medicaments having psychotropic properties
US4048335A (en) * 1974-06-17 1977-09-13 The Regents Of The University Of Michigan Method of inhibiting myocardial ischemia in mammals using quaternary salts
US5110977A (en) * 1990-02-14 1992-05-05 Eastman Kodak Company Ester-containing quaternary ammonium salts as adhesion improving toner charge agents
CA2095495C (en) * 1992-06-01 2002-06-04 Stephen Carl Hasselberg Assay for serum cholinesterase
US5451394A (en) * 1993-08-25 1995-09-19 Isp Van Dyk Inc. Quaternary salts of para-dialkylamino benzamide derivatives
FR2717174B1 (fr) * 1994-03-14 1996-05-31 Sanofi Sa Utilisation de pipéridinoéthyl esters de l'acide 4-amino-5-chloro-2-méthoxybenzoïque comme 5-HT4 agonistes.

Also Published As

Publication number Publication date
IL150180A0 (en) 2002-12-01
WO2001044218A1 (en) 2001-06-21
HUP0204014A2 (hu) 2003-03-28
ZA200205568B (en) 2003-10-13
EP1278736A1 (en) 2003-01-29
NZ519746A (en) 2004-05-28
YU44202A (sh) 2005-11-28
BR0016430A (pt) 2002-08-20
US20040214867A1 (en) 2004-10-28
CZ20022096A3 (cs) 2003-02-12
HUP0204014A3 (en) 2005-04-28
IS6415A (is) 2002-06-12
MXPA02006050A (es) 2004-08-23
EE200200316A (et) 2003-08-15
AU2334601A (en) 2001-06-25
JP2003516982A (ja) 2003-05-20
NO20022869L (no) 2002-08-14
KR20020075871A (ko) 2002-10-07
RU2002116211A (ru) 2004-02-10
CN1423641A (zh) 2003-06-11
PL355904A1 (en) 2004-05-31
NO20022869D0 (no) 2002-06-14

Similar Documents

Publication Publication Date Title
BG106814A (bg) Четвъртични соли на n-заместени циклични или ациклични амини като лекарствени средства
PL325312A1 (en) Methaguanidine, urea, thiourea or azacyclic derivatives of aminobenzoic acid as antagonists of integrin
EA200602067A1 (ru) Производные хиноксалин-2-она, содержащие их средства защиты полезных растений и способ их получения и их применение
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
PL328310A1 (en) Derivatives of quinazoline
GR3032311T3 (en) Stilbene derivatives and pharmaceutical compositions containing them
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
CA2263319A1 (en) Quinazoline derivatives and pharmaceutical compositions containing them
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
FI962418A (fi) Syklisiä amidijohdannaisia neurokiniini A antagonisteina
ATE132868T1 (de) Azabicyclo- und azacyclooxime und -amine mit cholinergischer wirkung und ihre pharmazeutisch annehmbaren salze
YU44102A (sh) Ciklična kvaternerna amonijum jedinjenja
BG104314A (bg) Антагонисти на витронектинов рецептор
DE69427517D1 (de) Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
EP1304324A4 (en) SEROTONIN RECAPTURE INHIBITORS
CA2211128A1 (en) Epoxysuccinamide derivatives or salts thereof, and drugs containing the same
DE69814800D1 (de) Epoxysuccinamid-derivate oder ihre salze
DE69625913D1 (de) Inhibitor des erwerbs der abhängigkeit/resistenz gegen betäaubende analgetika
MY116103A (en) Pyridine-2, 3-dicarboxylic acid diamide derivatives and herbicides comprising said derivatives as active ingredient
WO2001062709A3 (de) Verwendung von 2-phenylendiaminderivaten zur behandlung von infektionen
BG106815A (bg) Четвъртичен амониеви съединения и приложението имкато противокашличен агент
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
MX9802192A (es) Derivados novedosos del acido piridona carboxilico o sus sales, y agentes antibacterianos que contienen los mismos como sus componentes efectivos.
EP1234576A4 (en) MEDICINE AGAINST EATING DISORDERS
HUP0002323A2 (hu) Fungicid keverékek